Nuntius Therapeutics
YC W21 ↗London, GB · Founded 2021 · 2 employees · 2 known investors
Nuntius develops programmable nanocarriers for drug delivery that can target tissues beyond the liver and utilize machine learning to optimize carrier performance. The company serves pharmaceutical and biotech organizations developing targeted therapeutics.
AI & Machine LearningBiotechDeep TechHealthtechGene TherapyNanomedicinein /company@ycombinatorycombinator.com ↗
Founders & leadership· Y Combinator alumni (W21)
Investors · 2
Companies House · registry record
View on Companies House ↗- Registered name
- NUNTIUS THERAPEUTICS LIMITED
- Company number
- 13130725
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 13 Jan 2021
- Registered office
- Unit 23 The Cobalt Building, Lower Pemberton, Ashford, Kent, TN25 4BF
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 12 Jan 2026 · next due 26 Jan 2027
Current officers · 2
- Ngai Ping Albert Kwok — director, appointed 13 Jan 2021
- Benita Nagel — director, appointed 13 Jan 2021
Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.